Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has announced its latest share repurchase activity as part of its $250 million buyback program. On March 6, 2026, the company purchased 251,580 ordinary shares at a volume-weighted average price of 1,224.70 pence per share, with individual transactions ranging from 1,214.00p to 1,234.00p. This brings the total shares repurchased since February 26, 2026, to 1,578,744 at a cost of £20.0 million. Following these transactions, Hikma holds 12,833,233 shares in treasury, with 220,307,709 ordinary shares currently in issue. The company intends to cancel the repurchased shares.

Disclaimer*

UK 100

Latest directors dealings